Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 46,22€(+21,66%). Der Median liegt bei 44,76€(+17,82%).
| Kaufen | 13 |
| Halten | 13 |
| Verkaufen | 0 |
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Stay Ahead of the Game With Qiagen (QGEN) Q1 Earnings: Wall Street's Insights on Key Metrics
Get a deeper insight into the potential performance of Qiagen (QGEN) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.» Mehr auf zacks.com
Activist Fivespan has a stake in Qiagen. Here are 3 levers to boost the company's growth and improve value
Management at Qiagen has done the hard things right, but there is now an opportunity for the company to grow faster and in a more focused way.» Mehr auf cnbc.com
QGEN or RGEN: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Qiagen (QGEN) and Repligen (RGEN). But which of these two stocks is more attractive to value investors?» Mehr auf zacks.com
Unternehmenszahlen
| (EUR) | Dez. 2024 | |
|---|---|---|
| Umsatz | 500,88 Mio | 8,75% |
| Bruttoeinkommen | 336,16 Mio | 7,67% |
| Nettoeinkommen | 84,88 Mio | 3,93% |
| EBITDA | 175,43 Mio | 6,04% |
Fundamentaldaten
| Metrik | Wert |
|---|---|
Marktkapitalisierung | 8,12 Mrd€ |
Anzahl Aktien | 216,12 Mio |
52 Wochen-Hoch/Tief | 42,69€ - 33,52€ |
| Dividenden | Nein |
Beta | 0,67 |
KGV (PE Ratio) | 109,03 |
KGWV (PEG Ratio) | −14,90 |
KBV (PB Ratio) | 2,55 |
KUV (PS Ratio) | 4,61 |
Unternehmensprofil
| Name | Qiagen NV |
| CEO | Thierry Bernard |
| Mitarbeiter | 5.067 |
Assets entdecken
Shareholder von Qiagen NV investieren auch in folgende Assets
